RxSight, Inc. Operating Expenses
RxSight, Inc. (RXST) reported Operating Expenses of $47.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-05
- RxSight, Inc. operating expenses for the quarter ending 2026-06-30 was $47.51M, a 0.27% decline year-over-year.
- RxSight, Inc. operating expenses for the quarter ending 2026-03-31 was $41.33M, a 5.96% increase year-over-year.
- RxSight, Inc. operating expenses for the quarter ending 2025-12-31 was $36.60M, a 2.18% decline year-over-year.
- RxSight, Inc. operating expenses for the quarter ending 2025-09-30 was $36.41M, a 5.69% increase year-over-year.
- RxSight, Inc. operating expenses for fiscal 2025 was $151.20M, a 11.34% increase from fiscal 2024.
- RxSight, Inc. operating expenses for fiscal 2024 was $135.80M, a 30.77% increase from fiscal 2023.
- RxSight, Inc. operating expenses for fiscal 2023 was $103.85M, a 22.69% increase from fiscal 2022.
- RxSight, Inc. operating expenses for fiscal 2022 was $84.65M, a 47.71% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47.51M 10-Q · filed 2026-08-05 | $96.23M 10-Q · filed 2026-08-05 | $125.44M derived: sum of 3 quarters · filed 2026-08-05 | $161.84M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $41.33M 10-Q · filed 2026-05-06 | $77.93M derived: sum of 2 quarters · filed 2026-05-06 | $114.33M derived: sum of 3 quarters · filed 2026-05-06 | $161.97M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | $36.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $73.00M derived: sum of 2 quarters · filed 2026-02-25 | $120.64M derived: sum of 3 quarters · filed 2026-08-05 | $151.20M 10-K · filed 2026-02-25 | ||
| 2025-09-30 | $36.41M 10-Q · filed 2025-11-05 | $84.05M derived: sum of 2 quarters · filed 2026-08-05 | $114.60M 10-Q · filed 2025-11-05 | $160.46M derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | $47.64M 10-Q · filed 2026-08-05 | $39.19M 10-Q · filed 2025-08-07 | $96.21M 10-Q · filed 2026-08-05 | $78.19M 10-Q · filed 2025-08-07 | $124.06M derived: sum of 3 quarters · filed 2026-08-05 | $158.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $39.00M 10-Q · filed 2026-05-06 | $76.42M derived: sum of 2 quarters · filed 2026-05-06 | $110.86M derived: sum of 3 quarters · filed 2026-05-06 | $143.45M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $37.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $71.86M derived: sum of 2 quarters · filed 2026-02-25 | $104.44M derived: sum of 3 quarters · filed 2026-02-25 | $135.80M 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $34.45M 10-Q · filed 2025-11-05 | $67.03M derived: sum of 2 quarters · filed 2025-11-05 | $98.39M 10-Q · filed 2025-11-05 | $126.89M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | $32.58M 10-Q · filed 2025-08-07 | $63.94M 10-Q · filed 2025-08-07 | $92.44M derived: sum of 3 quarters · filed 2026-02-25 | $118.69M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | $31.36M 10-Q · filed 2025-05-07 | $59.86M derived: sum of 2 quarters · filed 2026-02-25 | $86.10M derived: sum of 3 quarters · filed 2026-02-25 | $111.74M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | $28.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $54.75M derived: sum of 2 quarters · filed 2026-02-25 | $80.39M derived: sum of 3 quarters · filed 2026-02-25 | $103.85M 10-K · filed 2026-02-25 | ||
| 2023-09-30 | $26.24M 10-Q · filed 2024-11-07 | $51.88M derived: sum of 2 quarters · filed 2024-11-07 | $75.34M 10-Q · filed 2024-11-07 | $97.76M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $25.64M 10-Q · filed 2024-08-05 | $49.10M 10-Q · filed 2024-08-05 | $71.52M derived: sum of 3 quarters · filed 2025-02-25 | $92.83M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $23.46M 10-Q · filed 2024-05-06 | $45.88M derived: sum of 2 quarters · filed 2025-02-25 | $67.19M derived: sum of 3 quarters · filed 2025-02-25 | $87.77M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $22.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $43.73M derived: sum of 2 quarters · filed 2025-02-25 | $64.31M derived: sum of 3 quarters · filed 2025-02-25 | $84.65M 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $21.31M 10-Q · filed 2023-11-09 | $41.89M derived: sum of 2 quarters · filed 2023-11-09 | $62.23M 10-Q · filed 2023-11-09 | $79.77M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $20.58M 10-Q · filed 2023-08-07 | $40.92M 10-Q · filed 2023-08-07 | $58.45M derived: sum of 3 quarters · filed 2023-08-07 | $72.90M derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $20.34M 10-Q · filed 2023-05-09 | $37.87M derived: sum of 2 quarters · filed 2023-05-09 | $52.32M derived: sum of 3 quarters · filed 2023-05-09 | $65.39M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $17.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $31.98M derived: sum of 2 quarters · filed 2023-03-06 | $45.05M derived: sum of 3 quarters · filed 2023-03-06 | $57.30M 10-K · filed 2023-03-06 | ||
| 2021-09-30 | $14.45M 10-Q · filed 2022-11-07 | $27.52M derived: sum of 2 quarters · filed 2022-11-07 | $39.77M 10-Q · filed 2022-11-07 | $49.45M derived: sum of 4 quarters · filed 2022-11-07 | ||
| 2021-06-30 | $13.06M 10-Q · filed 2022-08-08 | $25.32M 10-Q · filed 2022-08-08 | $35.00M derived: sum of 3 quarters · filed 2022-08-08 | $44.63M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $12.25M 10-Q · filed 2022-05-05 | $21.94M derived: sum of 2 quarters · filed 2022-05-05 | $31.56M derived: sum of 3 quarters · filed 2022-05-05 | $39.90M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $9.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $19.31M derived: sum of 2 quarters · filed 2022-03-08 | $27.64M derived: sum of 3 quarters · filed 2022-03-08 | $37.12M 10-K · filed 2022-03-08 | ||
| 2020-09-30 | $9.63M 10-Q · filed 2021-11-10 | $17.96M derived: sum of 2 quarters · filed 2021-11-10 | $27.43M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $8.33M 10-Q · filed 2021-09-09 | $17.81M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |